Andrew Slack joined Exactis in 2018 as the Director of Medical Affairs. As a former clinical drug reviewer with Health Canada’s Therapeutic Products Directorate, he is experienced in the evaluation of clinical trial data for the assessment of the safety and efficacy of targeted cancer therapies. 


Andrew earned his PhD in McGill’s Department of Pharmacology & Therapeutics, investigating the role of epigenetic mechanisms in oncogenesis. Following his doctoral work, he trained as a Postdoctoral Fellow at the Texas Children’s Cancer Center and Baylor College of Medicine where he led efforts to identify and develop promising leads for the treatment of pediatric malignancies. 

5450 Chemin de la Côte-des-Neiges

Suite 522

Montréal, Qc

H3T 1Y6


  • White LinkedIn Icon
Send Us a Message

© 2020 by Exactis Innovation